PATH vs UTMD · P/E 19, rev $1.61B vs P/E 15, rev $9.2M
Uipath Inc (PATH) versus Utah Medical Products Inc (UTMD) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Utah Medical Products Inc (UTMD) is a medical instruments & supplies company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported UTMD revenue for 2024-12-31 was $9.2M. Net income was $2.9M. Revenue was down 8.5% from 2024-09-30 to 2024-12-31. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
Not investment advice. Open the PATH and UTMD stock pages for the full models.
Not investment advice.